Considering the neurological and neuropsychiatric manifestations of coronavirus disease 2019 (COVID-19), its early diagnosis is crucial. This Viewpoint aims to highlight these manifestations through multimodal neuroimaging studies reflecting neurochemical and structural impairment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acschemneuro.1c00467 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!